ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Recursos principais

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
AI Entrar Premium IconPremium Help Menu
Índice Bovespa
122.883,67
-1,31%
S&P 500
5.564,91
-0,88%
US Dollar vs BRL
5,825
-0,50%
Bitcoin
81.695,98
4,11%
Brent Oil
69,63
0,85%
As Melhores Corretoras Online
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. Canadá
  5. TSX
  6. VIVO Cannabis Inc (LABS)

  7. VIVO Cannabis Inc (LABS) Notícias

LABS

VIVO Cannabis (LABS)

VIVO Cannabis Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:TSX:LABS
DataHoraFonteTítuloCódigoCompanhia
10/02/202509:00PR Newswire (US)MediPharm Labs Announces Termination of the Proposed Sale of Napanee Facility to Kensana HealthTSX:LABSVIVO Cannabis Inc
16/01/202509:00PR Newswire (US)MediPharm Labs Provides Update on Previously Announced Sale of Napanee Facility to Kensana HealthTSX:LABSVIVO Cannabis Inc
08/01/202509:00PR Newswire (Canada)MediPharm Labs Enters Landmark Commercial Agreement with Laboratório Teuto in BrazilTSX:LABSVIVO Cannabis Inc
17/12/202409:29PR Newswire (US)MediPharm Labs to Sell its Napanee Facility to Kensana Health for $5.5MTSX:LABSVIVO Cannabis Inc
14/11/202409:00PR Newswire (US)MediPharm Labs Reports Third Quarter ResultsTSX:LABSVIVO Cannabis Inc
11/11/202408:15PR Newswire (Canada)MediPharm Labs Sets Date to Report Third Quarter 2024 Financial ResultsTSX:LABSVIVO Cannabis Inc
17/10/202408:35PR Newswire (Canada)MediPharm Labs Announces Departure of President and Co-Founder Keith StrachanTSX:LABSVIVO Cannabis Inc
17/09/202407:45PR Newswire (Canada)MediPharm Labs Announces $2.1M Debt RepaymentTSX:LABSVIVO Cannabis Inc
14/08/202408:00PR Newswire (US)MediPharm Labs Reports Second Quarter Results Closing in on Positive Adjusted EBITDA(1) as Gross Profit Continues to ImproveTSX:LABSVIVO Cannabis Inc
13/08/202409:00PR Newswire (US)/R E P E A T -- MediPharm Labs Sets Date to Report Second Quarter 2024 Financial Results/TSX:LABSVIVO Cannabis Inc
08/08/202417:30PR Newswire (US)MediPharm Labs Sets Date to Report Second Quarter 2024 Financial ResultsTSX:LABSVIVO Cannabis Inc
26/06/202418:15PR Newswire (US)MediPharm Labs Announces Voting Results From the 2024 Annual Meeting of ShareholdersTSX:LABSVIVO Cannabis Inc
20/06/202407:45PR Newswire (US)MediPharm Labs Acquires Advanced Medical Cannabis Delivery Method Technology from Remidose AerosolsTSX:LABSVIVO Cannabis Inc
15/05/202407:15PR Newswire (Canada)MediPharm Labs Reports First Quarter ResultsTSX:LABSVIVO Cannabis Inc
08/05/202417:30PR Newswire (US)MediPharm Labs Sets Date to Report First Quarter 2024 Financial ResultsTSX:LABSVIVO Cannabis Inc
27/03/202411:54PR Newswire (Canada)MediPharm Labs Provides Conference Call Recording DetailsTSX:LABSVIVO Cannabis Inc
27/03/202407:30PR Newswire (Canada)MediPharm Labs Reports Fourth Quarter and Full Year ResultsTSX:LABSVIVO Cannabis Inc
25/03/202407:30PR Newswire (Canada)MediPharm Labs Provides Update on German Cannabis LegalizationTSX:LABSVIVO Cannabis Inc
22/03/202407:30PR Newswire (US)MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2023 Financial ResultsTSX:LABSVIVO Cannabis Inc
07/02/202408:30PR Newswire (US)MediPharm Labs Achieves Pharmaceutical GMP Certification with Brazilian Health AuthorityTSX:LABSVIVO Cannabis Inc
22/12/202309:00PR Newswire (Canada)MediPharm Labs Provides Update on Board of Directors and Long Term Incentive ProgramTSX:LABSVIVO Cannabis Inc
08/11/202319:01PR Newswire (US)MediPharm Labs Sets Date to Report Third Quarter 2023 Financial ResultsTSX:LABSVIVO Cannabis Inc
25/10/202308:00PR Newswire (US)MediPharm Labs Update on $9M Settlement Agreement - All Tilray Shares Sold and Converted to CashTSX:LABSVIVO Cannabis Inc
02/10/202308:00PR Newswire (US)MediPharm Labs Settles an Outstanding Claim for $9MTSX:LABSVIVO Cannabis Inc
27/09/202308:15PR Newswire (Canada)MediPharm Labs Launches new GMP Products to the Australian Medical Cannabis MarketTSX:LABSVIVO Cannabis Inc
20/09/202308:00PR Newswire (US)MediPharm Labs Improves Domestic Sales Gross Margin with Termination of Shelter Cannabis Brands Royalty AgreementTSX:LABSVIVO Cannabis Inc
05/09/202308:39PR Newswire (US)MediPharm Labs Completes Sale of Vacant Land for Cash Proceeds of $1.9 millionTSX:LABSVIVO Cannabis Inc
31/08/202309:02PR Newswire (US)MediPharm Labs Publishes Study Investigating Medical Cannabis Impacts on Anxiety and Depression Outcomes in Fibromyalgia PatientsTSX:LABSVIVO Cannabis Inc
14/08/202308:13PR Newswire (Canada)MediPharm Labs Reports Second Quarter Results with Doubling of Revenue and Record Margin GrowthTSX:LABSVIVO Cannabis Inc
10/08/202318:00PR Newswire (US)MediPharm Labs Sets Date to Report Second Quarter 2023 Financial ResultsTSX:LABSVIVO Cannabis Inc
 Apresentando as notícias mais relevantes sobre:TSX:LABS

Seu Histórico Recente

BOV
BHIA3
Grupo Casas Bahia ON
BOV
IBOV
Índice Bovespa
BOV
DASA3
DASA ON
BOV
PRIO3
PETRORIO ON
BOV
RNEW4
RENOVA PN
BOV
TPIS3
TRIUNFO PART ON
BOV
MGLU3
MAGAZINE LUIZA ON
BOV
PCAR3
PÃO DE AÇUCAR ON
BOV
AMER3
Americanas ON
BOV
TELB4
TELEBRAS PN
BOV
TECN3
TECHNOS ON
BOV
COGN3
COGNA ON
BOV
PDGR3
PDG REALT ON
BOV
GFSA3
GAFISA ON
BOV
IFCM3
Infracommerce Caxaas ON
BOV
PGMN3
Empreendimentos Pague Me... ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2025 ADVFN PLC - Todos os direitos reservados

Vá sem anúncios

Assine uma experiência sem anúncios

Sem anúncios

Experimente agora

Manter os anúncios